The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Non-Invasive Liquid Biopsy-Global Market Insights and Sales Trends 2025
Synopsis
Non-invasive liquid biopsy is to analyze and diagnose diseases such as cancer through blood or urine and other body fluids. At present, the main application area of liquid biopsy is the blood detection of tumors, that is, the use of blood to indicate tumor development and drug resistance and other information to guide individualized and precise treatment. Compared with existing tumor detection methods, liquid biopsy is non-invasive, can be detected frequently and repeatedly, and has rapid response capabilities. It has significant advantages and has great potential for application development.
The global Non-Invasive Liquid Biopsy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Non-Invasive Liquid Biopsy in various end use industries. The expanding demands from the Hospital, Laboratory and Others,, are propelling Non-Invasive Liquid Biopsy market. Stool Test, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Urine Test segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Non-Invasive Liquid Biopsy market, driven by demand from China, the second largest economy with some signs of stabilising, the Non-Invasive Liquid Biopsy market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Non-Invasive Liquid Biopsy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Non-Invasive Liquid Biopsy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Non-Invasive Liquid Biopsy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Non-Invasive Liquid Biopsy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Non-Invasive Liquid Biopsy covered in this report include Bio-Techne, Endress+Hauser, Exact Sciences Corporation, Lonza Group AG, MDxHealth, Merck KGaA, MutantDx, Norgen Biotek Corp and Nucleix, etc.
The global Non-Invasive Liquid Biopsy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bio-Techne
Endress+Hauser
Exact Sciences Corporation
Lonza Group AG
MDxHealth
Merck KGaA
MutantDx
Norgen Biotek Corp
Nucleix
Oasis Diagnostics Corporation
OraSure Technologies
PerkinElmer
Predicine
Qiagen
Thermo Fisher Scientific
Zymo Research Corporation
Global Non-Invasive Liquid Biopsy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Non-Invasive Liquid Biopsy market, Segment by Type:
Stool Test
Urine Test
Saliva Test
Others
Global Non-Invasive Liquid Biopsy market, by Application
Hospital
Laboratory
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Non-Invasive Liquid Biopsy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Non-invasive liquid biopsy is to analyze and diagnose diseases such as cancer through blood or urine and other body fluids. At present, the main application area of liquid biopsy is the blood detection of tumors, that is, the use of blood to indicate tumor development and drug resistance and other information to guide individualized and precise treatment. Compared with existing tumor detection methods, liquid biopsy is non-invasive, can be detected frequently and repeatedly, and has rapid response capabilities. It has significant advantages and has great potential for application development.
The global Non-Invasive Liquid Biopsy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Non-Invasive Liquid Biopsy in various end use industries. The expanding demands from the Hospital, Laboratory and Others,, are propelling Non-Invasive Liquid Biopsy market. Stool Test, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Urine Test segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Non-Invasive Liquid Biopsy market, driven by demand from China, the second largest economy with some signs of stabilising, the Non-Invasive Liquid Biopsy market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Non-Invasive Liquid Biopsy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Non-Invasive Liquid Biopsy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Non-Invasive Liquid Biopsy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Non-Invasive Liquid Biopsy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Non-Invasive Liquid Biopsy covered in this report include Bio-Techne, Endress+Hauser, Exact Sciences Corporation, Lonza Group AG, MDxHealth, Merck KGaA, MutantDx, Norgen Biotek Corp and Nucleix, etc.
The global Non-Invasive Liquid Biopsy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bio-Techne
Endress+Hauser
Exact Sciences Corporation
Lonza Group AG
MDxHealth
Merck KGaA
MutantDx
Norgen Biotek Corp
Nucleix
Oasis Diagnostics Corporation
OraSure Technologies
PerkinElmer
Predicine
Qiagen
Thermo Fisher Scientific
Zymo Research Corporation
Global Non-Invasive Liquid Biopsy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Non-Invasive Liquid Biopsy market, Segment by Type:
Stool Test
Urine Test
Saliva Test
Others
Global Non-Invasive Liquid Biopsy market, by Application
Hospital
Laboratory
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Non-Invasive Liquid Biopsy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Non-Invasive Liquid Biopsy
1.1 Non-Invasive Liquid Biopsy Market Overview
1.1.1 Non-Invasive Liquid Biopsy Product Scope
1.1.2 Non-Invasive Liquid Biopsy Market Status and Outlook
1.2 Global Non-Invasive Liquid Biopsy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Non-Invasive Liquid Biopsy Market Size by Region (2018-2029)
1.4 Global Non-Invasive Liquid Biopsy Historic Market Size by Region (2018-2023)
1.5 Global Non-Invasive Liquid Biopsy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Non-Invasive Liquid Biopsy Market Size (2018-2029)
1.6.1 North America Non-Invasive Liquid Biopsy Market Size (2018-2029)
1.6.2 Europe Non-Invasive Liquid Biopsy Market Size (2018-2029)
1.6.3 Asia-Pacific Non-Invasive Liquid Biopsy Market Size (2018-2029)
1.6.4 Latin America Non-Invasive Liquid Biopsy Market Size (2018-2029)
1.6.5 Middle East & Africa Non-Invasive Liquid Biopsy Market Size (2018-2029)
2 Non-Invasive Liquid Biopsy Market by Type
2.1 Introduction
2.1.1 Stool Test
2.1.2 Urine Test
2.1.3 Saliva Test
2.1.4 Others
2.2 Global Non-Invasive Liquid Biopsy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Non-Invasive Liquid Biopsy Historic Market Size by Type (2018-2023)
2.2.2 Global Non-Invasive Liquid Biopsy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Non-Invasive Liquid Biopsy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Non-Invasive Liquid Biopsy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Non-Invasive Liquid Biopsy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Non-Invasive Liquid Biopsy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Non-Invasive Liquid Biopsy Revenue Breakdown by Type (2018-2029)
3 Non-Invasive Liquid Biopsy Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Laboratory
3.1.3 Others
3.2 Global Non-Invasive Liquid Biopsy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Non-Invasive Liquid Biopsy Historic Market Size by Application (2018-2023)
3.2.2 Global Non-Invasive Liquid Biopsy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Non-Invasive Liquid Biopsy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Non-Invasive Liquid Biopsy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Non-Invasive Liquid Biopsy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Non-Invasive Liquid Biopsy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Non-Invasive Liquid Biopsy Revenue Breakdown by Application (2018-2029)
4 Non-Invasive Liquid Biopsy Competition Analysis by Players
4.1 Global Non-Invasive Liquid Biopsy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Non-Invasive Liquid Biopsy as of 2022)
4.3 Date of Key Players Enter into Non-Invasive Liquid Biopsy Market
4.4 Global Top Players Non-Invasive Liquid Biopsy Headquarters and Area Served
4.5 Key Players Non-Invasive Liquid Biopsy Product Solution and Service
4.6 Competitive Status
4.6.1 Non-Invasive Liquid Biopsy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bio-Techne
5.1.1 Bio-Techne Profile
5.1.2 Bio-Techne Main Business
5.1.3 Bio-Techne Non-Invasive Liquid Biopsy Products, Services and Solutions
5.1.4 Bio-Techne Non-Invasive Liquid Biopsy Revenue (US$ Million) & (2018-2023)
5.1.5 Bio-Techne Recent Developments
5.2 Endress+Hauser
5.2.1 Endress+Hauser Profile
5.2.2 Endress+Hauser Main Business
5.2.3 Endress+Hauser Non-Invasive Liquid Biopsy Products, Services and Solutions
5.2.4 Endress+Hauser Non-Invasive Liquid Biopsy Revenue (US$ Million) & (2018-2023)
5.2.5 Endress+Hauser Recent Developments
5.3 Exact Sciences Corporation
5.3.1 Exact Sciences Corporation Profile
5.3.2 Exact Sciences Corporation Main Business
5.3.3 Exact Sciences Corporation Non-Invasive Liquid Biopsy Products, Services and Solutions
5.3.4 Exact Sciences Corporation Non-Invasive Liquid Biopsy Revenue (US$ Million) & (2018-2023)
5.3.5 Lonza Group AG Recent Developments
5.4 Lonza Group AG
5.4.1 Lonza Group AG Profile
5.4.2 Lonza Group AG Main Business
5.4.3 Lonza Group AG Non-Invasive Liquid Biopsy Products, Services and Solutions
5.4.4 Lonza Group AG Non-Invasive Liquid Biopsy Revenue (US$ Million) & (2018-2023)
5.4.5 Lonza Group AG Recent Developments
5.5 MDxHealth
5.5.1 MDxHealth Profile
5.5.2 MDxHealth Main Business
5.5.3 MDxHealth Non-Invasive Liquid Biopsy Products, Services and Solutions
5.5.4 MDxHealth Non-Invasive Liquid Biopsy Revenue (US$ Million) & (2018-2023)
5.5.5 MDxHealth Recent Developments
5.6 Merck KGaA
5.6.1 Merck KGaA Profile
5.6.2 Merck KGaA Main Business
5.6.3 Merck KGaA Non-Invasive Liquid Biopsy Products, Services and Solutions
5.6.4 Merck KGaA Non-Invasive Liquid Biopsy Revenue (US$ Million) & (2018-2023)
5.6.5 Merck KGaA Recent Developments
5.7 MutantDx
5.7.1 MutantDx Profile
5.7.2 MutantDx Main Business
5.7.3 MutantDx Non-Invasive Liquid Biopsy Products, Services and Solutions
5.7.4 MutantDx Non-Invasive Liquid Biopsy Revenue (US$ Million) & (2018-2023)
5.7.5 MutantDx Recent Developments
5.8 Norgen Biotek Corp
5.8.1 Norgen Biotek Corp Profile
5.8.2 Norgen Biotek Corp Main Business
5.8.3 Norgen Biotek Corp Non-Invasive Liquid Biopsy Products, Services and Solutions
5.8.4 Norgen Biotek Corp Non-Invasive Liquid Biopsy Revenue (US$ Million) & (2018-2023)
5.8.5 Norgen Biotek Corp Recent Developments
5.9 Nucleix
5.9.1 Nucleix Profile
5.9.2 Nucleix Main Business
5.9.3 Nucleix Non-Invasive Liquid Biopsy Products, Services and Solutions
5.9.4 Nucleix Non-Invasive Liquid Biopsy Revenue (US$ Million) & (2018-2023)
5.9.5 Nucleix Recent Developments
5.10 Oasis Diagnostics Corporation
5.10.1 Oasis Diagnostics Corporation Profile
5.10.2 Oasis Diagnostics Corporation Main Business
5.10.3 Oasis Diagnostics Corporation Non-Invasive Liquid Biopsy Products, Services and Solutions
5.10.4 Oasis Diagnostics Corporation Non-Invasive Liquid Biopsy Revenue (US$ Million) & (2018-2023)
5.10.5 Oasis Diagnostics Corporation Recent Developments
5.11 OraSure Technologies
5.11.1 OraSure Technologies Profile
5.11.2 OraSure Technologies Main Business
5.11.3 OraSure Technologies Non-Invasive Liquid Biopsy Products, Services and Solutions
5.11.4 OraSure Technologies Non-Invasive Liquid Biopsy Revenue (US$ Million) & (2018-2023)
5.11.5 OraSure Technologies Recent Developments
5.12 PerkinElmer
5.12.1 PerkinElmer Profile
5.12.2 PerkinElmer Main Business
5.12.3 PerkinElmer Non-Invasive Liquid Biopsy Products, Services and Solutions
5.12.4 PerkinElmer Non-Invasive Liquid Biopsy Revenue (US$ Million) & (2018-2023)
5.12.5 PerkinElmer Recent Developments
5.13 Predicine
5.13.1 Predicine Profile
5.13.2 Predicine Main Business
5.13.3 Predicine Non-Invasive Liquid Biopsy Products, Services and Solutions
5.13.4 Predicine Non-Invasive Liquid Biopsy Revenue (US$ Million) & (2018-2023)
5.13.5 Predicine Recent Developments
5.14 Qiagen
5.14.1 Qiagen Profile
5.14.2 Qiagen Main Business
5.14.3 Qiagen Non-Invasive Liquid Biopsy Products, Services and Solutions
5.14.4 Qiagen Non-Invasive Liquid Biopsy Revenue (US$ Million) & (2018-2023)
5.14.5 Qiagen Recent Developments
5.15 Thermo Fisher Scientific
5.15.1 Thermo Fisher Scientific Profile
5.15.2 Thermo Fisher Scientific Main Business
5.15.3 Thermo Fisher Scientific Non-Invasive Liquid Biopsy Products, Services and Solutions
5.15.4 Thermo Fisher Scientific Non-Invasive Liquid Biopsy Revenue (US$ Million) & (2018-2023)
5.15.5 Thermo Fisher Scientific Recent Developments
5.16 Zymo Research Corporation
5.16.1 Zymo Research Corporation Profile
5.16.2 Zymo Research Corporation Main Business
5.16.3 Zymo Research Corporation Non-Invasive Liquid Biopsy Products, Services and Solutions
5.16.4 Zymo Research Corporation Non-Invasive Liquid Biopsy Revenue (US$ Million) & (2018-2023)
5.16.5 Zymo Research Corporation Recent Developments
6 North America
6.1 North America Non-Invasive Liquid Biopsy Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Non-Invasive Liquid Biopsy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Non-Invasive Liquid Biopsy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Non-Invasive Liquid Biopsy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Non-Invasive Liquid Biopsy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Non-Invasive Liquid Biopsy Market Dynamics
11.1 Non-Invasive Liquid Biopsy Industry Trends
11.2 Non-Invasive Liquid Biopsy Market Drivers
11.3 Non-Invasive Liquid Biopsy Market Challenges
11.4 Non-Invasive Liquid Biopsy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
